Although our study has significant translational implications, further investigations are needed to precisely measure the SRGN protein level in serum to monitor the chemotherapeutic response and for targeting SRGN-triggered signaling to improve chemotherapeutic efficacy in BC patients. Here, SRGN is linked to breast cancer.